Last update :
19/11/2024
Radiocontrast agent   Iopromide  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Biopromide Ecuador
Clarograf Spain
Ultragraf Germany
Ultravist Argentina, Austria, Belgium, Canada, Chile, Colombia, Denmark, Ecuador, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, India, Iran, Ireland, Italy, Luxembourg, Malaysia, Morocco, Netherlands, New Zealand, Norway, Peru, Portugal, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Tunisia, Turkey, United Arab Emirates, United States of America
Stability of mixtures   injection   Stability of mixtures : Iopromide     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polypropylene DC Beads® 310 mg I/ml
injection   Iopromide   
injection   Epirubicin hydrochloride 25 mg/ml
2-8°C
7 Day
Protect from light 3708
Level of evidence D
Polypropylene DC Beads® 300 mg I/ml
injection   Iopromide   
injection   Epirubicin hydrochloride 25 mg/ml
2-8°C
7 Day
Protect from light 3918
Level of evidence A

  Mentions Légales